End-of-Life Care for Blood Cancers: A Series of Focus Groups With Hematologic Oncologists

Abstract

Our analysis suggests that hematologic oncologists need better clinical markers for when to initiate EOL care. In addition, current quality measures may be inappropriate for identifying overly aggressive care for patients with blood cancers. Further research is needed to develop effective interventions to improve EOL care for this patient population.